Toh, H. et al., “Close structural resemblance between putatuve polymerase of a Drosophila transposable genetic element 17.6 abd pol gene product of Moloney murine leukaemia virus”, The EMBO Journal, vol. 4, No. 5, pp. 1267-1272, 1985. |
Ratner, L. et al., “Complete nucleotide sequence of the AIDS virus, HTLV-III”, Nature, vol. 313, pp. 277-284, 1985. |
Pearl, L. H. et al., “A structural model for retroviral proteases”, Nature, vol. 329, pp. 351-354, 1987. |
Kohl, N. E. et al., “Active human immunodeficiency virus protease in required for viral infection”, Proc. Natl. Acad. Sci. USA, vol. 85, pp. 4686-4690, 1988. |
Power, M.D. et al., “Nucleotide sequence of SRV-1, a type D Simian acquired immune deficiency syndrome retrovirus”, Science, Vol. 231, pp. 1567-1572, 1986. |
Kilby, J. M., et al., “Treatment of HIV-1 Infection—An Overview of New Strategies and Novel Agents”, Infections in Medicine, vol. 13, No. 10, pp. 903-911 (1996). |
Fischl, M. A., “Combination Antiretrovirial Therapy for HIV Infection”, Hospital Practice, pp. 43-48 (Jan. 15, 1994). |
Jablonowski, H., et al., “Antiretroviral Combination Therapy”, AIDS Forschung, vol. 9, No. 11, pp. 563-567 (1994) (English Translation, copy of original enclosed, too). |
Vella, S., et al., “Combination Therapy in the Management of HIV Infection”, Meth. Find. Exp. Clin. Pharmacol., vol. 18, No. Suppl C, pp. 23-26 (1996). |
Johnson, V., “Combination therapy for HIV-1 infection-overview: preclinical and clinical analysis of antiretroviral combinations”, Antiviral Research, vol. 29, pp. 35-39 (1996). |